Recent General News

SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers (March 23, 2017)

People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy... Continue Reading

Dealing with Distress (March 17, 2017)

Why it’s important to acknowledge distress during cancer care and what to do about it By Teresa L. Deshields and Clorinda Walley The moment a patient is diagnosed with cancer, one symptom is likely to... Continue Reading

Xermelo-new option for controlling symptoms of Carcinoid Syndrome (March 1, 2017)

The US Food and Drug Administration (FDA) today approved the oral therapy Xermelo (telotristat ethyl) to be used in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid... Continue Reading

Cancer Connect Launches On line Community for Patients with Neuroendocrine Tumors (February 23, 2017)

Sun Valley ID & Austin TX— OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for individuals with neuroendocrine tumors (NET). This community will provide... Continue Reading

It’s in the Genes: Genetic Testing Tutorial (October 7, 2016)

Advances in genetic testing are offering women more information than ever before about their genetic makeup and are providing opportunities for empowered decision making related to a wide range of health... Continue Reading

Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101 (July 19, 2016)

Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration... Continue Reading

FDA Designates Breakthrough Therapy Designation for Azedra in Pheochromocytoma and Paraganglioma (August 12, 2015)

The U.S. Food and Drug Administration (FDA) has designated Azedra as a Breakthrough Therapy for the treatment of patients with iobenguane-avid metastatic or recurrent pheochromocytoma and paraganglioma.... Continue Reading

Tips for Cancer Caregivers: November is National Family Caregiver Month (November 10, 2014)

Caring for a family member or friend with cancer is often very challenging. The experience can be exhausting both mentally and physically, but it actually becomes even more so when you don’t take care... Continue Reading

Study Suggest That Psoriasis Patients Have Increased Cancer Risk (October 15, 2014)

Based on recently analyzed data from a retrospective analysis of commercial insurance claims, rates of cancer are higher in patients with psoriasis and that some anti-psoriatic drugs may pose a higher... Continue Reading

Anamorelin May Be First Drug to Treat Cancer Cachexia (October 14, 2014)

A new drug, anamorelin, may be the first ever to effectively improve cancer cachexia. These findings were presented at the 2014 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, September... Continue Reading

« Previous PageNext Page »